ARCHIVES

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011